FIELD: medicine.
SUBSTANCE: recipients are isolated who have been exposed to extracorporal membrane oxygenation technology for at least 24 hours and/or at least two of the following conditions have been identified: gram negative bacteremia after surgery, intraoperative blood loss of more than 500 ml, mechanical ventilation duration of more than 12 hours in the postoperative period. Such patients receive drug or drugs having a bactericidal or bacteriostatic activity against Pneumocystis jiroveci starting from 2-3 days after the operation, for 5-6 days intravenously at a therapeutic dose.
EFFECT: reduced toxic effect of multicomponent drug therapy as a result of a differentiated approach to administration of toxic and active agents against pneumocystis.
2 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SURGICAL TREATMENT OF FALSE ANEURYSM OF THE FEMORAL ARTERY | 2022 |
|
RU2789746C1 |
METHOD OF ANAESTHESIA FOR CAESAREAN SECTION IN PREGNANT WOMEN WITH EISENMENGER SYNDROME | 2023 |
|
RU2823109C1 |
METHOD FOR PREVENTION OF INFECTIOUS COMPLICATIONS OF BACTERIAL NATURE AFTER HEART SURGERY UNDER CONDITIONS OF ARTIFICIAL CIRCULATION | 2016 |
|
RU2638814C1 |
METHOD OF LABORATORY EVALUATION OF EXTRACORPORAL MEMBRANE OXYGENATION EFFECTIVENESS IN ADULT PATIENTS WITH ACUTE HEART FAILURE AFTER OPEN-HEART SURGERIES | 2016 |
|
RU2638808C1 |
CELLULAR SUSPENSION-BASE DRUG AND METHOD OF TREATMENT OF ACQUIRED IMMUNODEFICIENCY SYNDROME (HIV-INFECTION) USING THIS PREPARATION | 1994 |
|
RU2137484C1 |
METHOD FOR INDIRECT LEFT VENTRICULAR DRAINAGE IN PROSTHETIC HEART FUNCTION USING VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) METHOD | 2022 |
|
RU2782145C1 |
METHOD FOR HAEMODYNAMIC LEFT VENTRICULAR UNLOAD IN PERIPHERAL VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION | 2013 |
|
RU2526880C1 |
METHOD FOR DIAGNOSING BACTEREMIA ASSOCIATED WITH GRAM-NEGATIVE MICROORGANISMS IN HEART OR LUNG RECIPIENTS | 2021 |
|
RU2780280C1 |
METHOD FOR PREDICTION OF RISK OF EARLY ABDOMINAL COMPLICATIONS IN PATIENTS AFTER CORRECTION OF ACQUIRED HEART DISEASES IN CONDITIONS OF ARTIFICIAL CIRCULATION | 2020 |
|
RU2734056C1 |
METHOD OF ANTIBIOTIC THERAPY CORRECTION IN PATIENT OF CARDIOSURGICAL PROFILE | 2010 |
|
RU2430373C1 |
Authors
Dates
2017-05-22—Published
2016-03-28—Filed